ATXI · Avenue Therapeutics, Inc. · Investor Relations
$0.38
-0.05 (-10.71%)
At close · Mar 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report.”View the 10-Q filed Aug 7, 2026
Market Cap
$848,783
Shares
3.29M
Volume · Mar 19
173.84K
Avg daily vol (3M)
426.7K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-12-30 | Annual Meeting of Stockholders | Shareholder meeting |
Source: https://ir.avenuetx.com/